Best Polycystic kidney disease Treatment Clinics and Prices in India for Australians

International patients must follow the Transplantation of Human Organs and Tissues Act. This law requires patients to bring a living donor who is a near relative. Both parties need a Medical Visa. They also need approval from a government-appointed Authorisation Committee to proceed.

• Donor eligibility: Donors must be near relatives like parents, siblings, children, or a spouse.
• Medical Visa: Recipient and donor must enter India on a specific M-Visa category.
• Embassy certification: The home embassy must issue Form 21 certifying the donor-patient relationship.
• Mandatory committee: Patients must attend a personal interview with a state-appointed Authorisation Committee.

Bookimed Expert Insight: India ranks fourth globally in patient requests served. This is largely due to transplant hubs like Apollo Hospital Indraprastha and Global Hospital Chennai. These centres manage many complex cases, including combined heart-kidney and lung transplants. Technical expertise is abundant, but the legal process is rigid. Matching the donor relationship to Form 21 requirements is the most critical step.

Patient Consensus: Patients highlight that the legal file must be complete before any surgery. They advise verifying donor relationship rules between Indian states. Some hospitals have stricter committee review processes than others.

Polycystic kidney disease cannot be cured permanently in India or elsewhere. This genetic condition causes fluid-filled cysts to grow. Indian specialists focus on managing blood pressure and slowing cyst growth. High-volume transplant centres offer the best long-term solution for kidney failure.

• Symptomatic treatment: Doctors prescribe targeted medications to control pain and prevent infections.
• Specific management: Tolvaptan therapy is available to slow the growth of kidney cysts.
• Transplantation centres: Apollo Hospital Indraprastha and Global Hospital Chennai manage over 1,000,000 international patients.
• Robotic technology: Aster CMI Hospital uses robotic surgery and 3D printing for transplants.

Bookimed Expert Insight: India ranks 4th globally for patient requests on our platform. Major networks like Manipal and Apollo serve millions of patients. This high volume allows surgeons to specialise in complex PKD-related transplants. Global Hospital Chennai was even first to perform combined heart-kidney transplants locally.

Patient Consensus: Patients note that India is excellent for accessing affordable dialysis and transplant services. They emphasise focusing on symptom control rather than looking for a genetic cure. Success depends on tracking kidney size and blood pressure closely with experienced nephrologists.

Kidney transplant success in India for polycystic kidney disease (PKD) patients is excellent. Long-term graft survival reaches approximately 83% over six years. Overall patient survival is around 76% in the same period. Leading Indian centres report immediate organ function in 90% of cases.

• Graft survival: Living donor success rates reach approximately 82.9% after nearly six years.
• Patient survival: Long-term survival for living donor recipients is approximately 75.7%.
• Immediate function: Up to 90% of patients see the new kidney work right away.
• Rejection rates: Biopsy-proven acute rejection is low, occurring in only 10.9% of cases.

Bookimed Expert Insight: India houses some of the world's largest transplant programs. Apollo Hospital Indraprastha performs more transplants than most US centres. Major clinics like Global Hospital Chennai and Aster CMI specialise in robotic-assisted transplants. This technology helps manage the limited abdominal space often found in PKD patients.

Patient Consensus: Patients note that success depends more on the surgical team's track record than the location. Many emphasise confirming how specialists in India will coordinate immunosuppression monitoring with their GP once they return to Australia.

Most patients do not require native kidney removal before a transplant in India. Specialists prefer leaving them intact to preserve residual function and avoid surgical risks. Removal is only mandatory if massive kidneys leave no room for the donor organ. It is also required if they cause severe chronic infections.

• Surgical criteria: Removal occurs only for intractable pain, persistent bleeding, or suspected malignancy.
• Space constraints: Massive kidney volume may physically block the implantation of the new organ.
• Timing options: Surgeons may perform nephrectomy months before or simultaneously with the transplant.
• Clinical benchmarks: Leading centres like Global Hospital Chennai specialise in complex multi-organ transplant cases.
• Diagnostic review: Specialists at Aster CMI Hospital use 3D printing to plan for abdominal space.

Bookimed Expert Insight: Indian tertiary centres like Apollo Hospital Indraprastha and Manipal Hospitals handle huge patient volumes. They often see more than 1,000,000 patients annually. This high frequency allows surgeons to refine ‘simultaneous’ protocols. In these sessions, they remove a native kidney and transplant the new one together. Patients should ask if their surgical team uses robotic systems, like the Da Vinci at Dr. Rela Institute. These systems help minimise recovery time for complex dual procedures.

Patient Consensus: Patients emphasise that the decision for removal is highly individual. It depends heavily on recent CT scans. They suggest getting a written surgical plan before travelling to India. This helps patients understand if a staged or combined approach is proposed.

Tolvaptan is the primary medication available in India to slow cyst growth in polycystic kidney disease patients. JCI-accredited centres like Apollo Hospital Indraprastha and Manipal Hospitals provide these disease-modifying therapies. These medications effectively delay kidney function decline in rapidly progressing cases.

• Targeted therapy: Tolvaptan blocks vasopressin to slow fluid accumulation and cyst expansion.
• Generic availability: Indian manufacturers provide affordable versions approved by the national regulator.
• Supportive care: Doctors use ACE inhibitors like Telmisartan to manage blood pressure effectively.
• Specialist usage: Somatostatin analogues like Octreotide may be used for polycystic liver symptoms.

Bookimed Expert Insight: India is a global hub for nephrology. It serves over 1,000,000 international patients annually at hubs like Apollo. Major centres like Global Hospital Chennai offer a distinct advantage. They combine specialised drug protocols with expertise in combined heart-kidney or liver-kidney transplants. This integrated approach gives patients a clear path from medication through to surgical options.

India offers specialised centres for polycystic kidney disease (PKD) and transplants. These include Apollo Hospital Indraprastha, Gleneagles Global Health City, and Medanta Hospital. These facilities specialise in high-volume, multi-organ transplants. They routinely manage complex cases involving massive kidneys or liver involvement.

• Apollo Hospital Indraprastha: This Delhi-based facility operates one of the world's largest transplantation centres.
• Gleneagles Global Health City: A leader in multi-organ transplants, including combined heart-kidney procedures in Chennai.
• Medanta Hospital: This Gurgaon-based institute serves over 20,000 international and local patients annually.
• Global Hospital Mumbai: Noted for performing the first combined kidney-liver transplant in Western India.
• Aster CMI Hospital: Specialists here use robotic surgery and 3-D printing for precise organ transplants.

Bookimed Expert Insight: Many centres handle routine transplants. However, patients with massive PKD kidneys should look for JCI-accredited facilities. Gleneagles Global Health City and Medanta have specific experience in combined organ surgeries. This is vital when PKD involves both the renal system and the liver.

Patient Consensus: Patients believe it's essential to choose tertiary hospitals with dedicated transplant programmes. They highlight that teams should include anaesthetists and radiologists. These experts must be experienced with the challenges of very enlarged polycystic kidneys.

Polycystic kidney disease patients in India must limit sodium and manage fluid intake. They should control protein while avoiding high-potassium ingredients like coconut and pickles. Management aims to lower blood pressure and slow cyst growth. Specialised renal care is available at JCI (Joint Commission International) accredited facilities. These include Artemis Hospitals and Apollo Hospital Indraprastha.

• Sodium control: Avoid pickles, papads, and packaged spice mixes to keep blood pressure down.
• Hydration tracking: Maintain high fluid intake in early stages unless fluid retention occurs.
• Protein choice: Prioritise plant-based proteins like cooked pulses over red meats and heavy dairy.
• Mineral management: Leach potatoes and spinach to remove potassium when kidney function is lower.
• Supplement safety: Avoid unverified Ayurvedic tonics to prevent accidental kidney damage or mineral spikes.

Bookimed Expert Insight: Major centres like Manipal Hospitals and Global Hospital Chennai treat over 80,000 patients annually. Indian cuisine relies heavily on hidden potassium sources like coconut and tamarind. Because of this, patients should request a formal renal meal plan. High-volume transplant centres often have dedicated renal dietitians. These experts can adapt local dishes to specific eGFR levels.

Patient Consensus: Patients note it is essential to request low-sodium versions of restaurant dishes. They suggest packing plain, unsalted snacks for travel days. Patients should always check with a nephrologist before trying local herbal teas or traditional kidney cleanses.